A mutation in Irak2c identifies IRAK-2 as a central component of the TLR regulatory network of wild-derived mice

Journal of Experimental Medicine

Volumn 206, Issue 7, 2009, Pages 1615-1631

  Conner, James R ^a,b   Smirnova, Irina I ^a   Poltorak, Alexander ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR ASSOCIATED KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENE; GENE DELETION; GENE LOCUS; GENE MAPPING; GENE MUTATION; IRAK2C GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CYTOKINES; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-6; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 67650507028     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20090490     Document Type: Article

References (52)

1. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell. 124:783-801.
2. Beebe, A.M., S. Mauze, N.J. Schork, and R.L. Coffman. 1997. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity. 6:551-557.
3. Beutler, B., Z. Jiang, P. Georgel, K. Crozat, B. Croker, S. Rutschmann, X. Du, and K. Hoebe. 2006. Genetic analysis of host resistance: toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24:353-389.
4. Bonizzi, G., and M. Karin. 2004. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280-288.
5. Burns, K., S. Janssens, B. Brissoni, N. Olivos, R. Beyaert, and J. Tschopp. 2003. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197:263-268.
6. Cao, Z., W.J. Henzel, and X. Gao. 1996. IRAK: a kinase associated with the interleukin-1 receptor. Science. 271:1128-1131.
7. Conner, J.R., I.I. Smirnova, and A. Poltorak. 2008. Forward genetic analysis of Toll-like receptor responses in wild-derived mice reveals a novel anti-inflammatory role for IRAK1BP1. J. Exp. Med. 205:305-314.
8. Doyle, S.L., and L.A. O'Neill. 2006. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem. Pharmacol. 72:1102-1113.
9. Fitzgerald, K.A., E.M. Palsson-McDermott, A.G. Bowie, C.A. Jefferies, A.S. Mansell, G. Brady, E. Brint, A. Dunne, P. Gray, M.T. Harte, et al. 2001. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 413:78-83.
10. Foster, S.L., D.C. Hargreaves, and R. Medzhitov. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature. 447:972-978.
11. Frazer, K.A., E. Eskin, H.M. Kang, M.A. Bogue, D.A. Hinds, E.J. Beilharz, R.V. Gupta, J. Montgomery, M.M. Morenzoni, G.B. Nilsen, et al. 2007. A sequence-based variation map of 8.27 million SNPs in inbred mouse strains. Nature. 448:1050-1053.
12. Gregory, R.C., D.J. Taxman, D. Seshasayee, M.H. Kensinger, J.J. Bieker, and D.M. Wojchowski. 1996. Functional interaction of GATA1 with erythroid Kruppel-like factor and Sp1 at defined erythroid promoters. Blood. 87:1793-1801.
13. Grove, M., and M. Plumb. 1993. C/EBP, NF-kappa B, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1 alpha immediate-early gene. Mol. Cell. Biol. 13:5276-5289.
14. Guenet, J.L., and F. Bonhomme. 2003. Wild mice: an ever-increasing contribution to a popular mammalian model. Trends Genet. 19:24-31.
15. Hardy, M.P., and L.A. O'Neill. 2004. The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory. J. Biol. Chem. 279:27699-27708.
16. Hoebe, K., E. Janssen, and B. Beutler. 2004. The interface between innate and adaptive immunity. Nat. Immunol. 5:971-974.
17. Ideraabdullah, F.Y., E. de la Casa-Esperon, T.A. Bell, D.A. Detwiler, T. Magnuson, C. Sapienza, and F.P. de Villena. 2004. Genetic and haplotype diversity among wild-derived mouse inbred strains. Genome Res. 14:1880-1887.
18. Iwami, K.I., T. Matsuguchi, A. Masuda, T. Kikuchi, T. Musikacharoen, and Y. Yoshikai. 2000. Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. J. Immunol. 165:6682-6686.
19. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987-995.
20. Janssens, S., and R. Beyaert. 2003. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell. 11:293-302.
21. Janssens, S., K. Burns, J. Tschopp, and R. Beyaert. 2002. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88. Curr. Biol. 12:467-471.
22. Kawagoe, T., S. Sato, K. Matsushita, H. Kato, K. Matsui, Y. Kumagai, T. Saitoh, T. Kawai, O. Takeuchi, and S. Akira. 2008. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9:684-691.
23. Kawai, T., and S. Akira. 2006. TLR signaling. Cell Death Differ. 13:816-825.
24. Keating, S.E., G.M. Maloney, E.M. Moran, and A.G. Bowie. 2007. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination. J. Biol. Chem. 282:33435-33443.
25. Kobayashi, K., L.D. Hernandez, J.E. Galan, C.A. Janeway Jr., R. Medzhitov, and R.A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 110:191-202.
26. LeBouder, E., J.E. Rey-Nores, N.K. Rushmere, M. Grigorov, S.D. Lawn, M. Affolter, G.E. Griffin, P. Ferrara, E.J. Schiffrin, B.P. Morgan, and M.O. Labeta. 2003. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immunol. 171:6680-6689.
27. Leulier, F., and B. Lemaitre. 2008. Toll-like receptors-taking an evolutionary approach. Nat. Rev. Genet. 9:165-178.
28. Li, S., A. Strelow, E.J. Fontana, and H. Wesche. 2002. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. USA. 99:5567-5572.
29. Merika, M., and S.H. Orkin. 1995. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Kruppel family proteins Sp1 and EKLF. Mol. Cell. Biol. 15:2437-2447.
30. Mestas, J., and C.C. Hughes. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172:2731-2738.
31. Muzio, M., J. Ni, P. Feng, and V.M. Dixit. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 278:1612-1615.
32. Nathan, C. 2002. Points of control in inflammation. Nature. 420:846-852.
33. Oda, K., and H. Kitano. 2006. A comprehensive map of the toll-like receptor signaling network. Mol. Syst. Biol. 2:2006-0015.
34. Park, J.M., F.R. Greten, A. Wong, R.J. Westrick, J.S. Arthur, K. Otsu, A. Hoffmann, M. Montminy, and M. Karin. 2005. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-kappaB as key regulators. Immunity. 23:319-329.
35. Philipsen, S., and G. Suske. 1999. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 27:2991-3000.
36. Saccani, S., S. Pantano, and G. Natoli. 2002. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat. Immunol. 3:69-75.
37. Sancho-Shimizu, V., and D. Malo. 2006. Sequencing, expression, and functional analyses support the candidacy of Ncf2 in susceptibility to Salmonella typhimurium infection in wild-derived mice. J. Immunol. 176:6954-6961.
38. Sanjabi, S., K.J. Williams, S. Saccani, L. Zhou, A. Hoffmann, G. Ghosh, S. Gerondakis, G. Natoli, and S.T. Smale. 2005. A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation. Genes Dev. 19:2138-2151.
39. Schadt, E.E., J. Lamb, X. Yang, J. Zhu, S. Edwards, D. Guhathakurta, S.K. Sieberts, S. Monks, M. Reitman, C. Zhang, et al. 2005. An integrative genomics approach to infer causal associations between gene expression and disease. Nat. Genet. 37:710-717.
40. Sebastiani, G., V. Blais, V. Sancho, S.N. Vogel, M.M. Stevenson, P. Gros, J.M. Lapointe, S. Rivest, and D. Malo. 2002. Host immune response to Salmonella enterica serovar Typhimurium infection in mice derived from wild strains. Infect. Immun. 70:1997-2009.
41. Shakhov, A.N., M.A. Collart, P. Vassalli, S.A. Nedospasov, and C.V. Jongeneel. 1990. κ B-type enhancers are involved in lipopolysaccharide- mediated transcriptional activation of the tumor necrosis factor κ gene in primary macrophages. J. Exp. Med. 171:35-47.
42. Siedlar, M., M. Frankenberger, E. Benkhart, T. Espevik, M. Quirling, K. Brand, M. Zembala, and L. Ziegler-Heitbrock. 2004. Tolerance induced by the lipopeptide Pam3Cys is due to ablation of IL-1R-associated kinase-1. J. Immunol. 173:2736-2745.
43. Staelens, J., B. Wielockx, L. Puimege, F. Van Roy, J.L. Guenet, and C. Libert. 2002. Hyporesponsiveness of SPRET/Ei mice to lethal shock induced by tumor necrosis factor and implications for a TNF-based antitumor therapy. Proc. Natl. Acad. Sci. USA. 99:9340-9345.
44. Suzuki, N., S. Suzuki, G.S. Duncan, D.G. Millar, T. Wada, C. Mirtsos, H. Takada, A. Wakeham, A. Itie, S. Li, et al. 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature. 416:750-756.
45. Swantek, J.L., M.F. Tsen, M.H. Cobb, and J.A. Thomas. 2000. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J. Immunol. 164:4301-4306.
46. Thomas, J.A., J.L. Allen, M. Tsen, T. Dubnicoff, J. Danao, X.C. Liao, Z. Cao, and S.A. Wasserman. 1999. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J. Immunol. 163:978-984.
47. Urosevic, N., O.J. Silvia, M.Y. Sangster, J.P. Mansfield, S.I. Hodgetts, and G.R. Shellam. 1999. Development and characterization of new flavivirus-resistant mouse strains bearing Flv(r)-like and Flv(mr) alleles from wild or wild-derived mice. J. Gen. Virol. 80:897-906.
48. Verstrepen, L., T. Bekaert, T.L. Chau, J. Tavernier, A. Chariot, and R. Beyaert. 2008. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell. Mol. Life Sci. 65:2964-2978.
49. Wan, Y., H. Xiao, J. Affolter, T.W. Kim, K. Bulek, S. Chaudhuri, D. Carlson, T. Hamilton, B. Mazumder, G.R. Stark, et al. 2009. Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control. J. Biol. Chem. 284:10367-10375.
50. Waterston, R.H., K. Lindblad-Toh, E. Birney, J. Rogers, J.F. Abril, P. Agarwal, R. Agarwala, R. Ainscough, M. Alexandersson, P. An, et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature. 420:520-562.
51. Yamin, T.T., and D.K. Miller. 1997. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 272:21540-21547.
52. Yang, H., T.A. Bell, G.A. Churchill, and F. Pardo-Manuel de Villena. 2007. On the subspecific origin of the laboratory mouse. Nat. Genet. 39:1100-1107.